Compare ADT Inc (ADT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADT Inc vs Recursion Pharmaceuticals Inc — how do they compare? ADT Inc trades at $7.39 (market cap $5.44B), while Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B). The key difference: ADT Inc is far larger — about 3× Recursion Pharmaceuticals Inc's market cap, and ADT Inc pays a 2.95% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ADT | RXRX | |
|---|---|---|
Market Cap | $5.44B | $1.81B |
Sector | Industrials | Health |
52-Week High | $8.85 | $6.79 |
52-Week Low | $6.30 | $2.84 |
Enterprise Value | $13.13B | $1.33B |
Dividend Yield | 2.95% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADT Inc
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. ADT offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. It provides interactive home and business automation solutions designed to control access, react to movement, and sense carbon monoxide, flooding, changes in temperature or other environmental conditions, as well as address personal emergencies, such as injuries and medical emergencies. In addition, it offers professional monitoring of third-party devices through ADT Canopy platform. The product brands of the company are ADT and ADT Pulse, and Protection One brand.
Read more on ADT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
